Independently tested for purity, sterility, endotoxins, and heavy metalsbecause quality should be proven
How does Hexadecapeptide NL-BPC-157 differ from BPC-157
Limitations of approved use For example, VYLEESI is not indicated for: First, Postmenopausal women Next, Men Also, Enhancement of sexual performance Moreover, Treatment of erectile dysfunction In addition, Low desire caused by another medical or psychiatric condition Likewise, Low desire caused by relationship problems or medication effects Unregulated product concerns However, products sold as PT-141 outside regulated pharmaceutical channels may differ in peptide identity, salt form, concentration, sterility, endotoxin burden, residual solvents, degradation products, and dose uniformity
This minimizes mechanical stress on the peptide